Skip to search formSkip to main contentSkip to account menu

LY307161

Known as: LY 307161 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Glucagon-Like Peptide 1
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Biophysical signatures of noncovalent aggregates formed by a glucagonlike peptide-1 analog: a prototypical example of biopharmaceutical aggregation.
LY307161 is a 31 amino acid analog of glucagonlike peptide-1(7-37)OH susceptible to physical instability associated with… 
Review
2003
Review
2003
Glucagon-like peptide-1 synthetic analogs: new therapeutic agents for use in the treatment of diabetes mellitus.
Glucagon-like peptide-1-(7-36)-amide (GLP-1) is a potent blood glucose-lowering hormone now under investigation for use as a… 
2000
2000
The GLP-1 analogue, LY307161, potently lowers post prandial blood glucose in subjects with type 2 diabetes
2000
2000
The GLP-1 analogue LY307161 is resistant to degradation by DDP-IV and is fully active in vitro
2000
2000
LY307161, a glucagon like peptide (GLP-1) analogue with prolonged action, does not cause hypoglycaemia
2000
2000
LY307161: A GLP-1 analogue with extended time action and increased activity in vivo
2000
2000
The hypoglycemic effect of the GLP-1 analogue LY307161 is self-limiting in normal, fasted dogs
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)